| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |